3,4-methylenedioxyamphetamine has been researched along with Orphan Diseases in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Orphan Diseases: Rare diseases that have not been well studied.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez-Zúñiga, B | 1 |
| Pulido, R | 1 |
| Pousada, M | 1 |
| Armayones, M | 1 |
| Zou, L | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Orphan Diseases
| Article | Year |
|---|---|
The Role of Parent/Caregiver with Children Affected by Rare Diseases: Navigating between Love and Fear.
Topics: Caregivers; Child; Fear; Humans; Love; Parent-Child Relations; Qualitative Research; Rare Diseases | 2021 |
[Rare diseases need efforts of medical workers, let our love be not rare].
Topics: Health Personnel; Humans; Love; Rare Diseases | 2014 |